Nephros Inc Asset Resilience Ratio
Nephros Inc asset resilience ratio. Nephros Inc (NEPH) has an Asset Resilience Ratio of 0.56% as of March 2018. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Nephros Inc defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Nephros Inc (2004–2018)
Asset resilience ratio of Nephros Inc from 2004 to 2018. This chart shows how Nephros Inc's Asset Resilience Ratio has changed over time. Read NEPH liabilities breakdown for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Nephros Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Nephros Inc balance sheet assets.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $26.00K | 0.56% |
| Total Liquid Assets | $26.00K | 0.56% |
Asset Resilience Insights
- Limited Liquidity: Nephros Inc maintains only 0.56% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Nephros Inc Industry Peers by Asset Resilience Ratio
Compare Nephros Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Gan & Lee Pharmaceuticals Co Ltd
SHG:603087 |
Medical Instruments & Supplies | 7.81% |
|
Andon Health Co Ltd
SHE:002432 |
Medical Instruments & Supplies | 18.11% |
|
Caina Technology Co. Ltd.
SHE:301122 |
Medical Instruments & Supplies | 19.55% |
|
QITIAN Technology Group Co Ltd
SHE:300061 |
Medical Instruments & Supplies | 0.00% |
|
Visco Vision Inc.
TW:6782 |
Medical Instruments & Supplies | 0.98% |
|
Mark Dynamics Indonesia Tbk PT
JK:MARK |
Medical Instruments & Supplies | 6.64% |
|
Medeon Biodesign
TWO:6499 |
Medical Instruments & Supplies | 32.68% |
|
Ansell Ltd
AU:ANN |
Medical Instruments & Supplies | 7.53% |
Nephros Inc Asset Resilience Ratio by Year (2004–2018)
Nephros Inc asset resilience ratio by year from 2004 to 2018. The table below shows the annual Asset Resilience Ratio data for Nephros Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2018-12-31 | 0.00% | $0.00 | $10.56 Million | -- |
| 2017-12-31 | 0.40% | $20.00K | $4.98 Million | -0.61pp |
| 2016-12-31 | 1.01% | $27.00K | $2.68 Million | +0.83pp |
| 2008-12-31 | 0.17% | $7.00K | $4.04 Million | -46.43pp |
| 2007-12-31 | 46.60% | $4.70 Million | $10.09 Million | -7.59pp |
| 2006-12-31 | 54.19% | $2.80 Million | $5.17 Million | -3.32pp |
| 2005-12-31 | 57.51% | $4.50 Million | $7.82 Million | +8.39pp |
| 2004-12-31 | 49.12% | $6.00 Million | $12.21 Million | -- |
About Nephros Inc
Nephros, Inc., a commercial-stage company, develops and sells water filtration solutions for medical and commercial applications in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella a… Read more